| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | +108.0% | +32.2% |
| Cost of Revenue | $400K | +25.4% | -14.7% |
| Gross Profit | $773K | +215.5% | +84.9% |
| R&D Expense | $428K | -14.9% | -34.9% |
| SG&A Expense | $2.2M | +48.6% | +24.7% |
| Operating Income | -$3.4M | -18.7% | -5.5% |
| Net Income | -$3.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.4M | -56.1% | -62.4% |
| Accounts Receivable | $1.3M | +70.3% | +49.7% |
| Inventory | $1.4M | +98.3% | +124.7% |
| Current Assets | $6.5M | -33.8% | -41.5% |
| Total Assets | $10.4M | -6.7% | -20.5% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.5M | — | — |
| Capital Expenditures | $81K | — | — |
| Investing Cash Flow | -$831K | — | — |
| Financing Cash Flow | $6.3M | — | — |
| Free Cash Flow | -$8.6M | — | — |
| -20.6% |
| -4.9% |
| EPS (Basic) | -$0.40 | -11.1% | +89.0% |
| EPS (Diluted) | -$0.40 | -11.1% | +89.0% |
| $3.0M |
| +18.7% |
| -4.3% |
| Total Liabilities | $5.6M | +26.5% | +14.9% |
| Stockholders' Equity | $4.8M | -28.5% | -41.4% |